Methylprednisolone Completed Phase 4 Trials for Autoimmune Adrenocortical Failure Prevention

IndicationsStatusPurposePhase
CompletedPrevention4
clinicaltrials.gov IdentifierTitleDrugs
NCT00753597Rescue of Steroidogenic Capacity in Adrenocortical Failure Study (RADS)